1. Home
  2. ARWR vs KLC Comparison

ARWR vs KLC Comparison

Compare ARWR & KLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • KLC
  • Stock Information
  • Founded
  • ARWR 2003
  • KLC 1969
  • Country
  • ARWR United States
  • KLC United States
  • Employees
  • ARWR N/A
  • KLC N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • KLC
  • Sector
  • ARWR Health Care
  • KLC
  • Exchange
  • ARWR Nasdaq
  • KLC NYSE
  • Market Cap
  • ARWR 2.6B
  • KLC 2.4B
  • IPO Year
  • ARWR 1993
  • KLC 2024
  • Fundamental
  • Price
  • ARWR $19.90
  • KLC $19.71
  • Analyst Decision
  • ARWR Buy
  • KLC Buy
  • Analyst Count
  • ARWR 11
  • KLC 8
  • Target Price
  • ARWR $43.33
  • KLC $31.75
  • AVG Volume (30 Days)
  • ARWR 2.5M
  • KLC 457.0K
  • Earning Date
  • ARWR 02-10-2025
  • KLC 03-20-2025
  • Dividend Yield
  • ARWR N/A
  • KLC N/A
  • EPS Growth
  • ARWR N/A
  • KLC N/A
  • EPS
  • ARWR N/A
  • KLC 0.07
  • Revenue
  • ARWR $2,500,000.00
  • KLC $2,634,075,000.00
  • Revenue This Year
  • ARWR $3,336.78
  • KLC $7.08
  • Revenue Next Year
  • ARWR $124.29
  • KLC $7.37
  • P/E Ratio
  • ARWR N/A
  • KLC $280.29
  • Revenue Growth
  • ARWR N/A
  • KLC 6.76
  • 52 Week Low
  • ARWR $17.05
  • KLC $17.05
  • 52 Week High
  • ARWR $36.72
  • KLC $29.89
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 49.40
  • KLC N/A
  • Support Level
  • ARWR $17.57
  • KLC N/A
  • Resistance Level
  • ARWR $21.84
  • KLC N/A
  • Average True Range (ATR)
  • ARWR 1.06
  • KLC 0.00
  • MACD
  • ARWR 0.11
  • KLC 0.00
  • Stochastic Oscillator
  • ARWR 54.57
  • KLC 0.00

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

About KLC KINDERCARE LEARNING COMPANIES INC

KinderCare Learning Companies Inc is a private provider of early childhood education and care services (ECE) in the United States. It serves children ranging from 6 weeks to 12 years of age across its market- leading footprint of around 1,480 early childhood education centers with a capacity of more than 194,000 children and contracts for more than 650 before- and after-school sites located in 40 states and the District of Columbia. Its three go-to-market channels are KinderCare Learning Centers, KinderCare Education at Work, and Champions.

Share on Social Networks: